Like many vendors and service providers within the pre-clinical space, KCAS is getting ready for the upcoming Society of Toxicology (SOT) annual conference in Nashville, and the KCAS booth is one you should make a point to visit. At SOT, KCAS will showcase its extensive bioanalytical capabilities, including expertise in developing and validating bioanalytical methods, analyzing small and large molecules, and measuring biomarkers in various matrices. The team at KCAS is equipped to handle projects of any size and complexity, and they work closely with clients to provide customized solutions that meet their unique needs.
KCAS Director of Analytical Chemistry and GLP Pharma Formulations, David Masters-Moore, will be on hand at the conference to present three presentations on dose form analysis.
In preparation for the event, David shared some thoughts on the industry’s trends and KCAS’ expertise in this area: “It feels like the industry is shifting towards large molecules, with more than 60% of new drugs being biopharmaceuticals, peptides, proteins, and antibodies. However, there is a lack of large molecule expertise in many pre-clinical tox analytical labs, which has led to a high demand for Contract Research Organizations (CROs) with large molecule expertise.”
Both large and small pharma have had trouble finding CROs with the necessary skills to analyze large molecules. KCAS, on the other hand, has been able to meet this demand with more than 70% of its studies involving large molecule projects in the past three years. KCAS has been able to solve difficult analytical issues related to large molecules thanks to the complementary skills of their team. Some clients approached KCAS with difficult analyses, unsure if the team could handle them, but were pleasantly surprised by the results.
During his talks, David will present case studies that demonstrate KCAS’ ability to solve large molecule analytical issues, as well as small molecule case studies. He’ll also discuss how KCAS can meet fast timelines, with some clients giving them as little as two weeks to prepare for a study. Despite the short notice, KCAS has developed and validated methods quickly and completed sample analysis within three to five days.
For those interested in dose form analysis, David’s presentations are not to be missed.
His first presentation will be on Monday, March 20th, in the afternoon at the KCAS booth, and attendees can expect to learn more about the industry’s trends and KCAS’ expertise in this area. You’ll also find David at the KCAS booth holding presentations on Tuesday and Wednesday mornings.
In addition to the presentations, visitors to the KCAS booth can expect to have their questions answered, whether they’re curious about specific analyses or just looking to learn more about KCAS and its services. At KCAS, we are proud to offer a wide range of services to meet the needs of our clients. Whether you need help with clinical trial management, bioanalytical services, or pharmacokinetic analysis, we have the expertise and resources to deliver results that exceed your expectations. We would be honored to work with you if you are looking for a partner who will provide high-quality service, expertise, and support throughout your project.
Contact us today to learn more about our services and how we can help you meet your pre-clinical project needs!
———————————————————————-
More about KCAS’ Pre-clinical Services:
At KCAS, we understand the importance of providing exceptional customer service to our clients. Our success is directly linked to our ability to meet and exceed our client’s expectations. This is why we prioritize providing high-quality service at every stage of the customer journey.
We strive to create a customer-centric culture at KCAS, where every team member is committed to delivering outstanding service. From the moment you first contact us, we work hard to ensure you feel valued and supported. Our team is trained to listen to your needs and concerns, and we make it a point to respond to your queries and requests promptly and effectively.
At KCAS, we are proud to offer a wide range of services to meet the needs of our clients. Whether you need help with clinical trial management, bioanalytical services, or pharmacokinetic analysis, we have the expertise and resources to deliver results that exceed your expectations.
One of the keys to our success is our dedication to quality. We understand the importance of accuracy and precision in our work and have implemented rigorous quality control processes to ensure that our work meets the highest standards. Regulatory authorities audit our quality systems, and we are proud to have a track record of excellence in this area. Effective communication is essential to building strong relationships with our clients. We inform our clients at every project stage, providing regular updates and feedback. We are always available to answer your questions and address any concerns you may have, and we work hard to build open and transparent relationships with our clients.
At KCAS, we are committed to providing exceptional customer service to our clients.
We believe this is the foundation of our success, and we work tirelessly to meet and exceed your expectations. We would be honored to work with you if you are looking for a partner who will provide high-quality service, expertise, and support throughout your project.